blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3643304

EP3643304 - PHARMACEUTICAL NANOSUSPENSION FOR THE THERAPY OF HIV INFECTION [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  23.02.2023
Database last updated on 03.09.2024
FormerRequest for examination was made
Status updated on  27.03.2020
FormerThe international publication has been made
Status updated on  31.12.2018
Most recent event   Tooltip10.01.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Alla Chem, LLC
1835 E. Hallandale Bch Blvd 442
Hallandale Beach, FL 33009 / US
[2020/18]
Inventor(s)01 / IVASHCHENKO, Andrey Alexandrovich
ul. Abramtsevskaya 4 korp.2 kv.27
Moscow 127576 / RU
02 / SAVCHUK, Nikolay Filippovich
6300 Via Dos Valles
Rancho Santa Fe California 92067 / US
03 / KHVAT, Alexander Viktorovich
12272 Misty Blue St.
San Diego CA 92131 / US
 [2020/18]
Representative(s)Zellentin & Partner mbB Patentanwälte
Rubensstraße 30
67061 Ludwigshafen / DE
[N/P]
Former [2020/18]Zellentin & Partner mbB Patentanwälte
Rubensstrasse 30
67061 Ludwigshafen / DE
Application number, filing date18820046.314.02.2018
[2020/18]
WO2018RU00086
Priority number, dateRU2017012200322.06.2017         Original published format: RU 2017122003
[2020/18]
Filing languageRU
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018236249
Date:27.12.2018
Language:RU
[2018/52]
Type: A1 Application with search report 
No.:EP3643304
Date:29.04.2020
Language:EN
[2020/18]
Search report(s)International search report - published on:RU27.12.2018
(Supplementary) European search report - dispatched on:EP19.03.2021
ClassificationIPC:A61K9/10, A61K9/19, A61K31/18, A61P31/18, B82Y40/00, B82Y5/00, A61K9/00, A61K47/10, A61K47/26, C07C15/00, A61K31/055, A61K31/085, A61K31/164, B82B1/00
[2021/16]
CPC:
A61K9/0019 (EP,EA,US); A61K31/085 (EA,RU); A61K31/63 (EA,US);
A61K31/055 (EA,RU); A61K31/164 (EA,RU); A61K31/277 (EP);
A61K47/10 (EP); A61K47/26 (EP); A61K9/10 (EP,EA,RU,US);
A61K9/19 (EP,EA,RU,US); A61P31/18 (EP,EA,RU); B82B1/00 (EP,EA,RU,US) (-)
Former IPC [2020/18]A61K31/18, A61K9/10, A61K9/19, A61P31/18, B82Y40/00, B82Y5/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/18]
TitleGerman:PHARMAZEUTISCHE NANOSUSPENSION ZUR THERAPIE EINER HIV-INFEKTION[2020/18]
English:PHARMACEUTICAL NANOSUSPENSION FOR THE THERAPY OF HIV INFECTION[2020/18]
French:NANO-SUSPENSION PHARMACEUTIQUE POUR LE TRAITEMENT DE L'INFECTION PAR LE VIH[2020/18]
Entry into regional phase20.01.2020Translation filed 
22.01.2020National basic fee paid 
22.01.2020Search fee paid 
22.01.2020Designation fee(s) paid 
22.01.2020Examination fee paid 
Examination procedure22.01.2020Examination requested  [2020/18]
12.10.2021Amendment by applicant (claims and/or description)
22.02.2023Despatch of a communication from the examining division (Time limit: M04)
03.07.2023Reply to a communication from the examining division
Fees paidRenewal fee
02.03.2020Renewal fee patent year 03
07.05.2021Renewal fee patent year 04
28.02.2022Renewal fee patent year 05
28.02.2023Renewal fee patent year 06
10.01.2024Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
28.02.202104   M06   Fee paid on   07.05.2021
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]US2005239881  (DUNN JAMES P [US], et al);
 [XY]US2010063154  (DAVIDSON JAMES PRENTICE [US], et al);
International search[Y]UA26356  ;
 [XYA]US2010063154  (DAVIDSON JAMES PRENTICE [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.